SCHEMBL24670388

SCHEMBL24670388

NS(=O)(=O)c1cc(CCCO)cs1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 P00918 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670395 0.83 CA2 (0.42) CA2
SCHEMBL7145362 0.82 CA2 (0.50) CA2
SCHEMBL22012871 0.74 CA2 (0.46) CA2
SCHEMBL21963164 0.74 CA2 (0.50) CA2
SCHEMBL22012875 0.70 CA2 (0.59) CA2
SCHEMBL10391021 0.70 CA2 (0.60) CA2
SCHEMBL24668662 0.69 CA2 (0.50) CA2
SCHEMBL2170522 0.69 HTR6 (0.33) CA2
SCHEMBL86601 0.68 TNKS2 (0.38) CA2
SCHEMBL28685496 0.68 TNKS2 (0.34) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed